{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:29:26Z","timestamp":1776918566111,"version":"3.51.2"},"reference-count":65,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Stiftung Pro UKBB, Basel","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Surgery, University Hospital Basel","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201706920049"],"award-info":[{"award-number":["201706920049"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Neuroblastoma is a rare disease. Rare are also the possibilities to test new therapeutic options for neuroblastoma in clinical trials. Despite the constant need to improve therapy and outcomes for patients with advanced neuroblastoma, clinical trials currently only allow for testing few substances in even fewer patients. This increases the need to improve and advance preclinical models for neuroblastoma to preselect favorable candidates for novel therapeutics. Here we propose the use of a new patient-derived 3D slice-culture perfusion-based 3D model in combination with rapid treatment evaluation using isothermal microcalorimetry exemplified with treatment with the novel carbonic anhydrase IX and XII (CAIX\/CAXII) inhibitor SLC-0111. Patient samples showed a CAIX expression of 18% and a CAXII expression of 30%. Corresponding with their respective CAIX expression patterns, the viability of SH-EP cells was significantly reduced upon treatment with SLC-0111, while LAN1 cells were not affected. The inhibitory effect on SH-SY5Y cells was dependent on the induction of CAIX expression under hypoxia. These findings corresponded to thermogenesis of the cells. Patient-derived organotypic slice cultures were treated with SLC-0111, which was highly effective despite heterogeneity of CAIX\/CAXII expression. Thermogenesis, in congruence with the findings of the histological observations, was significantly reduced in SLC-0111-treated samples. In order to extend the evaluation time, we established a perfusion-based approach for neuroblastoma tissue in a 3D perfusion-based bioreactor system. Using this system, excellent tissue quality with intact tumor cells and stromal structure in neuroblastoma tumors can be maintained for 7 days. The system was successfully used for consecutive drug response monitoring with isothermal microcalorimetry. The described approach for drug testing, relying on an advanced 3D culture system combined with a rapid and highly sensitive metabolic assessment, can facilitate development of personalized treatment strategies for neuroblastoma.<\/jats:p>","DOI":"10.3390\/ijms23063128","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T03:06:10Z","timestamp":1647313570000},"page":"3128","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Perfusion-Based Bioreactor Culture and Isothermal Microcalorimetry for Preclinical Drug Testing with the Carbonic Anhydrase Inhibitor SLC-0111 in Patient-Derived Neuroblastoma"],"prefix":"10.3390","volume":"23","author":[{"given":"Zihe","family":"Huo","sequence":"first","affiliation":[{"name":"Department of Pediatric Surgery, University Children\u2019s Hospital Basel, 4031 Basel, Switzerland"},{"name":"Department of Clinical Research, University of Basel, 4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remo","family":"Bilang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, University Children\u2019s Hospital Basel, 4031 Basel, Switzerland"},{"name":"Department of Clinical Research, University of Basel, 4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[{"name":"Department Neurofarba, Sezione di Scienze Farmaceutiche, University of Florence, 50121 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"von der Weid","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, University of Basel, 4031 Basel, Switzerland"},{"name":"Department of Hematology and Oncology, University Children\u2019s Hospital Basel, 4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Bruder","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Basel, 4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1358-3439","authenticated-orcid":false,"given":"Stefan","family":"Holland-Cunz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, University Children\u2019s Hospital Basel, 4031 Basel, Switzerland"},{"name":"Department of Clinical Research, University of Basel, 4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6493-0432","authenticated-orcid":false,"given":"Ivan","family":"Martin","sequence":"additional","affiliation":[{"name":"Tissue Engineering, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-1916","authenticated-orcid":false,"given":"Manuele G.","family":"Muraro","sequence":"additional","affiliation":[{"name":"Tissue Engineering, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2213-4993","authenticated-orcid":false,"given":"Stephanie J.","family":"Gros","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, University Children\u2019s Hospital Basel, 4031 Basel, Switzerland"},{"name":"Department of Clinical Research, University of Basel, 4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc3526","article-title":"Neuroblastoma: Developmental biology, cancer genomics and immunotherapy","volume":"13","author":"Cheung","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4174\/astr.2020.99.2.118","article-title":"Nomogram for predicting overall survival in children with neuroblastoma based on SEER database","volume":"99","author":"Liang","year":"2020","journal-title":"Ann. Surg. Treat. Res."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kimura, S., Sekiguchi, M., Watanabe, K., Hiwatarai, M., Seki, M., Yoshida, K., Isobe, T., Shiozawa, Y., Suzuki, H., and Hoshino, N. (2021). Association of high-risk neuroblastoma classification based on expression profiles with differentiation and metabolism. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0245526"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.sempedsurg.2011.10.009","article-title":"Neuroblastoma","volume":"21","author":"Davidoff","year":"2012","journal-title":"Semin. Pediatr. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","article-title":"Childhood cancer survival in Europe 1999\u20132007: Results of EUROCARE-5\u2014A population-based study","volume":"15","author":"Gatta","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00441-018-2821-2","article-title":"Neuroblastoma: Clinical and biological approach to risk stratification and treatment","volume":"372","author":"Tolbert","year":"2018","journal-title":"Cell Tissue Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/21678707.2017.1304212","article-title":"Emerging and investigational therapies for neuroblastoma","volume":"5","author":"Applebaum","year":"2017","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_8","first-page":"26","article-title":"Challenges in drug development for children","volume":"15","author":"Adamson","year":"2017","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/ng.3921","article-title":"Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries","volume":"49","author":"Boeva","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_10","first-page":"CD010685","article-title":"Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation","volume":"8","author":"Peinemann","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tibtech.2003.12.001","article-title":"The role of bioreactors in tissue engineering","volume":"22","author":"Martin","year":"2004","journal-title":"Trends Biotechnol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/bit.25688","article-title":"Three dimensional multi-cellular muscle-like tissue engineering in perfusion-based bioreactors","volume":"113","author":"Cerino","year":"2016","journal-title":"Biotechnol. Bioeng."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"E5688","DOI":"10.1073\/pnas.1805440115","article-title":"In vitro biomimetic engineering of a human hematopoietic niche with functional properties","volume":"115","author":"Bourgine","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e1331798","DOI":"10.1080\/2162402X.2017.1331798","article-title":"Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments","volume":"6","author":"Muraro","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e1800300","DOI":"10.1002\/adbi.201800300","article-title":"Maintenance of Primary Human Colorectal Cancer Microenvironment Using a Perfusion Bioreactor-Based 3D Culture System","volume":"3","author":"Manfredonia","year":"2019","journal-title":"Adv. Biosyst."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e101654","DOI":"10.15252\/embj.2019101654","article-title":"Xenograft and organoid model systems in cancer research","volume":"38","author":"Bleijs","year":"2019","journal-title":"EMBO J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling Development and Disease with Organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Gros, S.J., Holland-Cunz, S.G., Supuran, C.T., and Braissant, O. (2019). Personalized Treatment Response Assessment for Rare Childhood Tumors Using Microcalorimetry-Exemplified by Use of Carbonic Anhydrase IX and Aquaporin 1 Inhibitors. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20204984"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: Mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"eabj0364","DOI":"10.1126\/sciadv.abj0364","article-title":"Genome-wide synthetic lethal screen unveils novel CAIX-NFS1\/xCT axis as a targetable vulnerability in hypoxic solid tumors","volume":"7","author":"Chafe","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: Suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4161\/cc.24902","article-title":"Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells","volume":"12","author":"Fiaschi","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_24","first-page":"404","article-title":"Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma","volume":"31","author":"Ameis","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00383-015-3831-8","article-title":"Influence of hypoxia-dependent factors on the progression of neuroblastoma","volume":"32","author":"Ameis","year":"2016","journal-title":"Pediatric Surg. Int."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ameis, H.M., Drenckhan, A., von Loga, K., Escherich, G., Wenke, K., Izbicki, J.R., Reinshagen, K., and Gros, S.J. (2013). PGK1 as predictor of CXCR4 expression, bone marrow metastases and survival in neuroblastoma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0083701"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"605272","DOI":"10.3389\/fcell.2021.605272","article-title":"AQP1 Is Up-Regulated by Hypoxia and Leads to Increased Cell Water Permeability, Motility, and Migration in Neuroblastoma","volume":"9","author":"Huo","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Pini, N., Huo, Z., Kym, U., Holland-Cunz, S., and Gros, S.J. (2021). AQP1-Driven Migration Is Independent of Other Known Adverse Factors but Requires a Hypoxic Undifferentiated Cell Profile in Neuroblastoma. Children, 8.","DOI":"10.3390\/children8010048"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/JEP.S265620","article-title":"Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors","volume":"12","author":"Supuran","year":"2020","journal-title":"J. Exp. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(17)30070-0","article-title":"Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1\/SIOPEN): An international, randomised, multi-arm, open-label, phase 3 trial","volume":"18","author":"Ladenstein","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_31","first-page":"e53193","article-title":"Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line","volume":"108","author":"Shipley","year":"2016","journal-title":"J. Vis. Exp. JoVE"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-319-38810-6_11","article-title":"Tumor Hypoxia: Causative Mechanisms, Microregional Heterogeneities, and the Role of Tissue-Based Hypoxia Markers","volume":"923","author":"Vaupel","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"16825","DOI":"10.1074\/jbc.R117.799973","article-title":"Oxygen availability and metabolic reprogramming in cancer","volume":"292","author":"Xie","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc.2017.77","article-title":"Tumour acidosis: From the passenger to the driver\u2019s seat","volume":"17","author":"Corbet","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: Links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1479-5876-8-57","article-title":"Proton dynamics in cancer","volume":"8","author":"Huber","year":"2010","journal-title":"J. Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res."},{"key":"ref_41","first-page":"69","article-title":"Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis","volume":"6","author":"Yaromina","year":"2016","journal-title":"Front. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.bjc.6603530","article-title":"Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer","volume":"96","author":"Hussain","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ciccone, V., Filippelli, A., Angeli, A., Supuran, C.T., and Morbidelli, L. (2020). Pharmacological Inhibition of CA-IX Impairs Tumor Cell Proliferation, Migration and Invasiveness. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082983"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Angeli, A., Carta, F., Nocentini, A., Winum, J.Y., Zalubovskis, R., Akdemir, A., Onnis, V., Eldehna, W.M., Capasso, C., and Simone, G. (2020). Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment. Metabolites, 10.","DOI":"10.3390\/metabo10100412"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2019.05.004","article-title":"Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia","volume":"157","author":"McDonald","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"109326","DOI":"10.1016\/j.cbi.2020.109326","article-title":"Combined 3-O-acetylbetulin treatment and carbonic anhydrase IX inhibition results in additive effects on human breast cancer cells","volume":"333","author":"Petrenko","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ward, C., Meehan, J., Gray, M., Kunkler, I.H., Langdon, S.P., and Argyle, D.J. (2018). Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness. Metabolites, 8.","DOI":"10.3390\/metabo8010013"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2020.01.015","article-title":"Preclinical models for neuroblastoma: Advances and challenges","volume":"474","author":"Nolan","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_49","first-page":"113","article-title":"Growth of multicell spheroids in tissue culture as a model of nodular carcinomas","volume":"46","author":"Sutherland","year":"1971","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2016.03.013","article-title":"Three-dimensional culture systems in cancer research: Focus on tumor spheroid model","volume":"163","author":"Nath","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/ijc.32572","article-title":"Reflection of neuroblastoma intratumor heterogeneity in the new OHC-NB1 disease model","volume":"146","author":"Thole","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.2147\/IJN.S159942","article-title":"Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models","volume":"13","author":"Foglietta","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.biomaterials.2015.05.037","article-title":"Bioreactor-engineered cancer tissue-like structures mimic phenotypes, gene expression profiles and drug resistance patterns observed \u201cin vivo\u201d","volume":"62","author":"Hirt","year":"2015","journal-title":"Biomaterials"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Huo, Z., Sa Santos, M., Drenckhan, A., Holland-Cunz, S., Izbicki, J.R., Nash, M.A., and Gros, S.J. (2021). Metastatic Esophageal Carcinoma Cells Exhibit Reduced Adhesion Strength and Enhanced Thermogenesis. Cells, 10.","DOI":"10.3390\/cells10051213"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/children8090784","article-title":"Increased Proliferation of Neuroblastoma Cells under Fructose Metabolism Can Be Measured by Isothermal Microcalorimetry","volume":"8","author":"Pini","year":"2021","journal-title":"Children"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.1356","article-title":"Cyclin E overexpression and amplification in human tumours","volume":"200","author":"Schraml","year":"2003","journal-title":"J. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/biot.201400494","article-title":"Isothermal microcalorimetry accurately detects bacteria, tumorous microtissues, and parasitic worms in a label-free well-plate assay","volume":"10","author":"Braissant","year":"2015","journal-title":"Biotechnol. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1002\/ijc.24980","article-title":"Complementary use of fluorescence and magnetic resonance imaging of metastatic esophageal cancer in a novel orthotopic mouse model","volume":"126","author":"Gros","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1158\/1535-7163.MCT-10-0209","article-title":"Effective therapeutic targeting of the overexpressed HER-2 receptor in a highly metastatic orthotopic model of esophageal carcinoma","volume":"9","author":"Gros","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ladenstein, R., Potschger, U., Valteau-Couanet, D., Luksch, R., Castel, V., Ash, S., Laureys, G., Brock, P., Michon, J.M., and Owens, C. (2020). Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1). Cancers, 12.","DOI":"10.3390\/cancers12020309"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S1470-2045(18)30578-3","article-title":"Interleukin 2 with anti-GD2 antibody ch14.18\/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1\/SIOPEN): A multicentre, randomised, phase 3 trial","volume":"19","author":"Ladenstein","year":"2018","journal-title":"Lancet. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1634\/stemcells.2005-0002","article-title":"Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts","volume":"23","author":"Braccini","year":"2005","journal-title":"Stem. Cells"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.jbiomech.2008.07.023","article-title":"Computational evaluation of oxygen and shear stress distributions in 3D perfusion culture systems: Macro-scale and micro-structured models","volume":"41","author":"Cioffi","year":"2008","journal-title":"J. Biomech."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1073\/pnas.1506684112","article-title":"Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma","volume":"112","author":"Santoro","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"H1278","DOI":"10.1152\/ajpheart.00787.2004","article-title":"Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers","volume":"288","author":"Radisic","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/6\/3128\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:36:28Z","timestamp":1760135788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/6\/3128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":65,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["ijms23063128"],"URL":"https:\/\/doi.org\/10.3390\/ijms23063128","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]}}}